BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative Employers
  Post Job | Search Resumes | Login

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Exponent Inc. 

149 Commonwealth Drive

Menlo Park  California  94025  U.S.A.
Phone: 888.656.EXPO or 650-326-9400 Fax: 650-326-8072


SEARCH JOBS
About Exponent

Exponent
is a scientific and engineering consulting firm that provides solutions to complex technical problems. With over 90 scientific and engineering disciplines, our staff of approximately 900, located in 19 offices throughout the nation and in 5 international offices, combines unparalleled technical expertise with the ability to focus this knowledge in extremely short time frames when necessary. Our multidisciplinary team of scientists, physicians, statisticians, engineers, and regulatory consultants perform either in-depth scientific research and analysis, or very rapid-response evaluations, tailored to provide our clients with the critical information required for both day-to-day and long-term strategic decisions. Exponent is certified to ISO 9001.

Exponent’s Pharmaceutical Expertise

Exponent provides the highest quality technical, regulatory, and safety assessment services to assist our clients with issues related to pharmaceutical and biotechnology products, as well as pre-clinical and clinical development, manufacturing, risk management, and regulatory support. We have several in-house staff with direct pharmaceutical experience, coming to Exponent from both large and small pharmaceutical and biotechnology companies. Our unique range of skills and experience in drug development helps our clients maximize the value of their research and development efforts in bringing medications to the market. Exponent provides a matrix of multidisciplinary services to the pharmaceutical industry and we can help you navigate the complex drug development process in the most efficient and cost-effective manner, providing expertise across all facets of the pharmaceutical industry, from idea to NDA.


 Key Statistics


Email: info@exponent.com
Ownership: Public

Web Site: Exponent Inc.
Employees: 900
Symbol: EXPO
 



Industry
Services






 Company News
Exponent Inc. (EXPO) Release: Failure Analysis, Product Recalls, and Liability: Preventative Measures to Help Prevent the FDA From Knocking on Your Door 12/20/2012 9:45:44 AM    More...
Exponent (EXPO) Reports Fourth Quarter and Fiscal Year 2008 Results 2/5/2009 11:24:02 AM    More...
Exponent (EXPO) to Announce Fourth Quarter and Fiscal Year 2008 Results 1/21/2009 9:13:44 AM    More...
Exponent (EXPO) Adds $35 Million to Stock Repurchase Program 6/4/2008 2:06:38 PM    More...
Exponent (EXPO) to Announce Third Quarter 2007 Results 10/12/2007 8:46:14 AM    More...
Exponent (EXPO) Reports Second Quarter 2007 Results 7/19/2007 9:30:30 AM    More...
Exponent (EXPO) Adds $35 Million to Stock Repurchase Program 5/29/2007 2:50:09 PM    More...
Exponent (EXPO) To Announce Fourth Quarter And Fiscal Year 2006 Results 1/17/2007 11:15:19 AM    More...
Exponent (EXPO) To Announce Third Quarter 2006 Results 10/6/2006 10:41:30 AM    More...
Exponent (EXPO) Reports First Quarter 2005 Financial Results 10/19/2005 5:13:08 PM    More...